Labo Suisse CRESCINA MITO FOLLICULAR ISLANDS for men 20vials 2100/1900/1700

Description

-Helps physiological hair growth in thinning areas. On single follicles and follicular islands
-Counteracts thinning scalp
-Effective in 100% of tested subjects*
-Formulations with differentiated dosages for different degrees of thinning

Crescina Transdermic Follicular Islands MITO is a dermo-cosmetic treatment in vials for topical use for the physiological growth of hair with patented Transdermal Technology thanks to which the active substances can penetrate the hair system not only via the transfollicular route (opening of the follicle) but also transdermally through the skin layers of the scalp (ex-vivo test with Franz Cells) aided both by their low molecular weight and by the presence of 5 enhancers (Rapid-Intensive formula base) which also favor a more rapid action of the preparation.

The formula is characterized by the Re-Growth complex (Cysteine, Lysine, Glycoprotein), the HFSC complex (Stem-Engine: Hydrolyzed Rice Protein and Corosolic Acid from Eriobotrya Japonica Extract), the Follicular Islands complex , 5 Enhancer , which is associated with the new MITO – Mitochondria (Nonapeptide-1, Magnesium Gluconate, Carnitine Fumarate) to help stimulate the hair system by promoting the activity of the preparation and promoting physiological hair growth.
Also present in the formulation are 12 Plate-Like molecules (Swiss Patent CH 713 030) and the Scalp Microbiome Complex , to rebalance the functionality of the beneficial microorganisms naturally present on the scalp. The formula contains Hair Booster 177 which supports the activity of the hair bulb and the ATP molecule linked to Ribose .

Indicated in cases of thinning due to physiological and non-pathological causes.
It does not act on completely atrophied follicles.

EFFECTIVE IN 100% OF THE SUBJECTS TESTED*

 From +7 to +41 new hairs in 1.8 cm²

Result after 4 months of double-blind, randomized and placebo-controlled in vivo clinical/instrumental test on 46 subjects (23 treated with Crescina HFSC and 23 with placebo). Male subjects had thinning grades II, III, III vertex and IV on the Hamilton-Norwood scale.

All subjects experienced positive results from a minimum of +7 to a maximum of +41 new hairs growing in an electronically counted area of ​​1.8 cm². The test results are statistically significant.